Updated July 9, 2009
Cervarix could save 'millions of women's lives throughout the world,' GSK exec says. Drug giant is seeking FDA approval in U.S.
Updated June 6, 2009
Drug giant releases results of its own study at diabetes conferencing that it says downplays heart attack risks. WHO, meanwhile, endorses GSK diarrhea drug.
Updated June 3, 2009
Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.
Updated May 22, 2009
Looking ahead, leaders of 13-county Research Triangle Regional Partnership outline new five-year plan for "Staying on Top." Recruiting pipeline is strong, RTRP’s top exec says. Since 2003, employment grew in all the region’s 13 counties but Warren, which lost 407 jobs.
Updated May 21, 2009
Milken Institute ranks RTP second for innovation as well as research and development. However, lack of 'risk capital' and entrepreneurship helps drag down its overall score.
Updated April 22, 2009
'It is essential that we reconfigure our U.S. business to make sure we have the right resource in the right areas and an overall lower level of infrastructure costs,' Andrew Witty says.
Updated April 17, 2009
As yet unnamed company will based U.S. operations in RTP where GSK has a long history of AIDS research. Venture will be No. 2 in HIV drug market share from launch.
Updated March 18, 2009
North Carolina native to help coordinate research efforts at N.C. Research Institute.
Updated October 17, 2008
Despite an increase of more than 6,000 jobs, the state’s jobless rate has hit its highest level in six years.
September 3, 2008
New and expanding companies announced more than $1 billion in investments in the 13-county region from June through August for projects estimated to create nearly 1,700 new jobs, according to a new report released by the Research Triangle Regional Partnership (RTRP).
Updated July 28, 2008
The Durham County Board of Commissioners voted unanimously Monday night to offer Merck, one of the world's largest pharmaceutical companies, a $2 million development incentive to expand its Treyburn Corporate Park facility.
July 21, 2008
The decision of the Golden LEAF Foundation to spend $262,248 in public funds to promote the biodefense project and respond to its critics smells.
July 1, 2008
Papas Ventures, which launched CoLucid in 2005, participates in new round. CoLucid has anti-migraine compound in development.
Updated June 19, 2008
The $300 million investment will bring the number of employee at the Durham facility to approximately 400.
Updated April 16, 2008
UniversityTech: Center for HIV/AIDS Vaccine Immunology at Duke, International AIDS Vaccine Initiative plan to "lay the groundwork for new vaccine approaches."